TRMED — Thor Medical ASA Share News
0.000.00%
Last trade - 00:00- NOK1.49bn
- NOK1.48bn
- NOK0.44m
Brief: Herantis Appoints Tone Kvåle As Chief Financial Officer
Brief: Nordic Nanovector: Results Of Preclinical Study Of Betalutin
Brief: Nordic Nanovector Says Considering To Conduct Repair Offering Of Up To 2.3 Mln New Shares
Brief: Nordic Nanovector Says Raised About NOK 231 Million Through Private Placement Of 13.2 Million New Shares
Brief: Nordic Nanovector Launches A Private Placement Of New Shares
Brief: Nordic Nanovector Q2 Operating Loss Widens To NOK 113.4 Million
Brief: Nordic Nanovector Announces EU Patent Granted Covering The Use Of Alpha37
Brief: Nordic Nanovector To Amend PARADIGME Trial Protocol
Brief: Nordic Nanovector Betalutin Receives Fast-Track Designation From US FDA
Brief: Nordic Nanovector Q1 Comprehensive Loss Stable At NOK 92 Mln
Brief: Nordic Nanovector's Betalutin Receives Positive Opinion For Orphan Drug Designation From EMA For Marginal Zone Lymphoma
Brief: Nordic Nanovector Granted US Patent
Brief: Nordic Nanovector Announces Changes To Its Executive Management Team
EU Biopharma: "No COVID-19 net beneficiaries" - Jefferies
Brief: Nordic Nanovector Says Annual General Meeting Will Now Be Held On 10 June
Brief: Nordic Nanovector To Reduce Staff By Around 20%
Brief: Nordic Nanovector Names Lars Nieba Interim CEO
Brief: Nordic Nanovector Awarded NOK 12 Million In Funding From The Norwegian Research Council
Brief: Nordic Nanovector Provides Update On Lymrit 37-05 Phase 1 DLBCL Trial